Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 2
2004 4
2005 6
2006 15
2007 16
2008 18
2009 27
2010 33
2011 56
2012 73
2013 89
2014 145
2015 156
2016 200
2017 199
2018 208
2019 316
2020 254
Text availability
Article attribute
Article type
Publication date

Search Results

1,620 results
Results by year
Filters applied: . Clear all
Page 1
Ulcerative colitis: towards remission.
Eisenstein M. Eisenstein M. Nature. 2018 Nov;563(7730):S33. doi: 10.1038/d41586-018-07276-2. Nature. 2018. PMID: 30405234 No abstract available.
Probiotics and prebiotics in ulcerative colitis.
Derikx LA, Dieleman LA, Hoentjen F. Derikx LA, et al. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):55-71. doi: 10.1016/j.bpg.2016.02.005. Epub 2016 Feb 9. Best Pract Res Clin Gastroenterol. 2016. PMID: 27048897 Review.
The intestinal microbiota is one of the key players in the etiology of ulcerative colitis. Manipulation of this microflora with probiotics and prebiotics is an attractive strategy in the management of ulcerative colitis. Several intervention stu …
The intestinal microbiota is one of the key players in the etiology of ulcerative colitis. Manipulation of this microfl …
Chronic ulcerative colitis and colorectal cancer.
Rogler G. Rogler G. Cancer Lett. 2014 Apr 10;345(2):235-41. doi: 10.1016/j.canlet.2013.07.032. Epub 2013 Aug 11. Cancer Lett. 2014. PMID: 23941831 Free article. Review.
One of the most important consequences of chronically active ulcerative colitis (UC) or Crohn's disease (CD) - the two major forms of inflammatory bowel disease (IBD) - is the development of colorectal cancer (CRC). ...Recent data indicate that the intestinal …
One of the most important consequences of chronically active ulcerative colitis (UC) or Crohn's disease (CD) - the two …
A comprehensive review and update on ulcerative colitis().
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. Gajendran M, et al. Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. Dis Mon. 2019. PMID: 30837080 Review.
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflammation extending from the rectum to the more proximal colon, with variable extents. ...In addition to confirming the diagnosis of UC, it is …
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflam …
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, Xuan W, Lin E, Mitchell HM, Borody TJ. Paramsothy S, et al. Lancet. 2017 Mar 25;389(10075):1218-1228. doi: 10.1016/S0140-6736(17)30182-4. Epub 2017 Feb 15. Lancet. 2017. PMID: 28214091 Clinical Trial.
BACKGROUND: The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its efficacy in ulcerative colitis is uncertain. W …
BACKGROUND: The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota …
Fecal microbiota transplantation in ulcerative colitis.
Blanchaert C, Strubbe B, Peeters H. Blanchaert C, et al. Acta Gastroenterol Belg. 2019 Oct-Dec;82(4):519-528. Acta Gastroenterol Belg. 2019. PMID: 31950808 Free article. Review.
This paper tries to determine whether FMT is safe and effective in the treatment of ulcerative colitis, and what the potential characteristics could be of a 'super donor'. METHODS: The PubMed database was searched using the term fecal microbiota transplantati …
This paper tries to determine whether FMT is safe and effective in the treatment of ulcerative colitis, and what the potential …
Festschrift for Ronan O'Connell: pouchitis, ulcerative colitis and the microbiome.
Lavelle A. Lavelle A. Ir J Med Sci. 2018 Nov;187(4):1133-1137. doi: 10.1007/s11845-018-1785-2. Epub 2018 Mar 9. Ir J Med Sci. 2018. PMID: 29524104 Review.
The hypothesis of altered bacterial communities contributing to the development of pouchitis began a scientific quest to link host mucosal factors, microbial metabolism and spatial structure of the colonic microbiome in ulcerative colitis, reaching its apothe …
The hypothesis of altered bacterial communities contributing to the development of pouchitis began a scientific quest to link host mucosal f …
Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, Rufo P, Baker SS, Sauer C, Markowitz J, Pfefferkorn M, Oliva-Hemker M, Rosh J, Otley A, Boyle B, Mack D, Baldassano R, Keljo D, LeLeiko N, Heyman M, Griffiths A, Patel AS, Noe J, Kugathasan S, Walters T, Huttenhower C, Hyams J, Xavier RJ. Schirmer M, et al. Cell Host Microbe. 2018 Oct 10;24(4):600-610.e4. doi: 10.1016/j.chom.2018.09.009. Cell Host Microbe. 2018. PMID: 30308161 Free PMC article.
Evaluating progression risk and determining optimal therapy for ulcerative colitis (UC) is challenging as many patients exhibit incomplete responses to treatment. As part of the PROTECT (Predicting Response to Standardized Colitis Therapy) Study, we evaluated …
Evaluating progression risk and determining optimal therapy for ulcerative colitis (UC) is challenging as many patients exhibi …
Novel insights into microbiome in colitis and colorectal cancer.
Yang Y, Jobin C. Yang Y, et al. Curr Opin Gastroenterol. 2017 Nov;33(6):422-427. doi: 10.1097/MOG.0000000000000399. Curr Opin Gastroenterol. 2017. PMID: 28877044 Free PMC article. Review.
PURPOSE OF REVIEW: Microbiota is a major player in the pathogenesis of inflammatory bowel diseases (IBD) and colorectal cancer (CRC). Here, we summarize the key advances achieved in the past 18 months (ending June 2017) toward a better understanding of the role of micro …
PURPOSE OF REVIEW: Microbiota is a major player in the pathogenesis of inflammatory bowel diseases (IBD) and colorectal cancer (CRC). …
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM. Costello SP, et al. JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046. JAMA. 2019. PMID: 30644982 Free PMC article. Clinical Trial.
IMPORTANCE: High-intensity, aerobically prepared fecal microbiota transplantation (FMT) has demonstrated efficacy in treating active ulcerative colitis (UC). ...
IMPORTANCE: High-intensity, aerobically prepared fecal microbiota transplantation (FMT) has demonstrated efficacy in treating active …
1,620 results
Jump to page
Feedback